New cell therapy aims to speed immune recovery in SCID kids after transplant
NCT ID NCT03879876
First seen May 22, 2026 · Last updated Jun 09, 2026 · Updated 2 times
Summary
This early-phase study tested whether injecting special immune-building cells (HTLPs) could safely and quickly restore the immune system in 4 children with severe combined immunodeficiency (SCID) after a partially matched stem cell transplant. The goal was to help their bodies make T cells faster, reducing infection risk. The study focused on safety and how well the immune system recovered.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC PATIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Unité d'Immunologie Hématologie Rhumatologie Pédiatrique (UIHR),
Paris, Île-de-France Region, 75015, France
Conditions
Explore the condition pages connected to this study.